Last reviewed · How we verify

Licensed COVID-19 Vaccine — Competitive Intelligence Brief

Licensed COVID-19 Vaccine (Licensed COVID-19 Vaccine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

phase 1 Biologic Live · refreshed every 30 min

Target snapshot

Licensed COVID-19 Vaccine (Licensed COVID-19 Vaccine) — BioNTech SE. The vaccine uses mRNA to instruct cells to produce a harmless piece of the spike protein, triggering an immune response.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Licensed COVID-19 Vaccine TARGET Licensed COVID-19 Vaccine BioNTech SE phase 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Licensed COVID-19 Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/licensed-covid-19-vaccine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: